Dedicated Breast CT for Quantitative Breast Density Measurements in Mexican-origin Women in Southern Arizona
1 other identifier
observational
92
1 country
1
Brief Summary
The overall objective of this clinical study is to determine the feasibility of breast CT for breast density assessment and association of CT-derived density measures with metabolic syndrome in overweight/obese Mexican-origin women in Southern Arizona. These evaluations will help support follow-up clinical research utilizing breast density acquired by breast CT as a surrogate endpoint biomarker to evaluate breast cancer preventive strategies. The long-term goal of these research efforts is to develop safe and effective preventive strategies to reduce obesity-associated breast cancer burden in our catchment area.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 11, 2021
CompletedFirst Posted
Study publicly available on registry
March 16, 2021
CompletedStudy Start
First participant enrolled
April 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedMay 21, 2024
May 1, 2024
2 years
March 11, 2021
May 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measurement of breast density
To determine the feasibility of applying a novel clinical prototype of breast CT to assess breast density on non-compressed breasts. Feasibility will be evaluated by the proportion of unmeasurable breast density within our study population utilizing computerized tomography (CT) scan.
Baseline
Secondary Outcomes (2)
Determine the association between metabolic syndrome and breast CT-derived density measures.
Two years
Comparison of CT-derived breast density measures versus the individual components of metabolic syndrome.
Two years
Study Arms (1)
All Participants
Interventions
This is a cross-sectional clinical study to determine the feasibility of breast CT for breast density assessment and association of CT-derived density measures with metabolic syndrome in overweight/obese Mexican-origin women in Southern Arizona. There is no intervention.
Eligibility Criteria
Overweight/obese Mexican-origin women in Southern Arizona.
You may qualify if:
- Women with BMI of 25 kg/m2 or greater
- years of age
- Must self-identify as Mexican-origin living in Southern Arizona
- Ability to understand and the willingness to sign a written informed consent document in English or Spanish
You may not qualify if:
- Women who are pregnant or lactating
- Women who have undergone treatment of chemotherapy and/or radiation for any malignancies within the past 2 years, excluding non-melanoma skin cancer or cancer confined to organs with surgical removal as the only treatment
- Women who have breast implants
- Women who have used selective estrogen receptor modulators, aromatase inhibitors, and /or hormone replacement therapy within the past 12 months.
- Women who have undergone bilateral mastectomy
- Women with physical limitations that may prohibit resting prone on the exam table, such as, but not limited to: frozen shoulder, recent heart surgery, pace maker
- Women who are unable to tolerate study constraints, frail, or unable to cooperate
- Women who weigh more than 440 lbs (200 Kg), which is the weight limit for the patient support table of the BCT system
- Women who have received radiation treatments to the thorax for malignant and nonmalignant conditions, such as (but not limited to) treatment for enlarged thymus gland as an infant, irradiation for benign breast conditions, including breast inflammation after giving birth, and treatment for Hodgkin's disease
- Women who have received large number of diagnostic x-ray examinations of the horax for monitoring of disease such as (but not limited to) tuberculosis, and severe scoliosis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Arizona
Tucson, Arizona, 85724, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sherry Chow, PhD
University of Arizona
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 11, 2021
First Posted
March 16, 2021
Study Start
April 28, 2022
Primary Completion
May 1, 2024
Study Completion
May 1, 2024
Last Updated
May 21, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share